A device for treating leakage from an external orifice in the body of a patent which comprises a first member having a body-contacting first surface and an opposing second surface about an aperture, which first surface is attachable to the patient with said aperture positioned over said orifice, and a second member integral with said second surface, which second member comprises a valve mounted over said aperture, which valve has a closed position which prevents leakage of fluid through the device and an open position which allows fluid to flow through said aperture when desired, the closed and open positions being achievable without removing the device from the body of the patient.
|
2. A device for alleviating urinary incontinence in a patient having a urethra and an external urethral orifice, which device comprises:
a first member having a body-contacting first surface and an opposing second surface situated about an aperture, which first surface is attachable to the patient with said aperture positioned over the patient's urethral orifice and without any structure of the device projecting into the patient's urethra, and a second member integral with said second surface, which second member comprises a valve mounted over said aperture, which valve has a closed position which prevents leakage of urine through the device and an open position which allows urine from the urethral orifice to flow through said aperture upon micturition, the closed and open positions being achievable without removing the device from the patient.
1. A device for restricting leakage from an external orifice of a patient's urethra, which device comprises:
a body-contacting first surface, and an opposing second surface situated about an aperture, which first surface is attachable to an external surface of the patient with said aperture positioned over the orifice of the urethra so that the device may be associated with the patient without any structure projecting into the urethra of the patient, and a second member integral with said second surface, which second member comprises a valve mounted over said aperture, which valve has a closed position which prevents leakage of fluid through the device and an open position which allows fluid from the orifice of the urethra to flow through said aperture when desired, the closed and open positions being achievable without removing the device from the body of the patient.
3. A device according to
4. A device according to
5. A device according to
6. A device according to
7. A device according to
8. A device according to
9. A modification of the device according to
10. A modification of the device according to
|
This application is a continuation of U.S. application Ser. No. 08/984,976, filed Dec. 4, 1997, now U.S. Pat. No. 6,056,687.
This invention relates to a device for alleviating urinary incontinence. More particularly, the invention is concerned with a device which facilitates control of urination by preventing undesirable leakage of urine and yet allowing micturition when required without removal of the device from the body of the patient. A most preferred embodiment of the device is for alleviating urinary incontinence. particularly stress incontinence, in a female patient. An embodiment for use with a male patient is also included. A further embodiment for dealing with leakage from a body stoma is also contemplated.
Urinary incontinence, which is a condition involving involuntary loss of urine, is a problem with very many patients, particularly female patients, throughout the world. Sometimes the problem is treated with surgery. However, when the patient can not receive surgery or suffers only from a partial loss of urine, the problem may be treated non-surgically by use of an internal (intra-urethral or intra-vaginal) or external device. A number of external female devices have been proposed in the art.
For example, U.S. Pat. No. 5,074,855 discloses a device for controlling urinary incontinence in a human female comprising a resilient pad configured to seal against and occlude the urethral meatus of the user. A similar device is disclosed in U.S. Pat. No. 5,336,208. In both these devices, an adhesive is provided to seal the body of the device against the urethral meatus.
International Applications No. 96/39989, 96/39990 and 96/39991 each disclose a adfemale urinary incontinence device in the form of a urethral cap with a partially deformable body portion, a hand gripping portion and a body contacting surface. The body portion defines a chamber which allows for a vacuum seal when applied to the patient's body.
Each of the above devices prevents urinary leakage by occluding the external urethral orifice and each has to be removed by the patient to allow micturition.
It is desirable to have a device which satisfactorily prevents leakage and also facilitates micturition without the need to remove the device from the body of the patient. It has now been found that these desiridata may be achieved by a device which incorporates an easily operable valve which prevents leakage when closed and allows flow when open.
According to the invention there is provided a device for treating leakage from an external orifice in the body of a patient, which device comprises a first member having a body contacting first surface and an opposing second surface about an aperture, which first surface is attachable to the body of the patient with- said aperture positioned over said orifice, and a second member integral with said second surface, which second member comprises a valve mounted over said aperture, which valve has a closed position which prevents leakage of fluid through the device and an open position which allows fluid from said orifice to flow through said aperture when desired, the closed and open positions being achievable without removing the device from the body of the patient.
When the external orifice is a urethral orifice the fluid is urine and accordingly the invention provides, as a preferred embodiment, a device for alleviating urinary incontinence in a patient having an external urethral orifice, which device comprises a first member having a body-contacting first surface and an opposing second surface about an aperture, which first surface is attachable to the patient with said aperture positioned over said urethral orifice, and a second member integral with said second surface, which second member comprises a valve mounted over said aperture, which valve has a closed position which prevents leakage of urine through the device and an open position which allows urine from said urethral orifice to flow through said aperture upon micturition, the closed and open positions being achievable without removing the device from the patient.
In a further preferred embodiment at least a portion of said first surface is coated with a biologically-compatible adhesive, i.e. a medical adhesive, to facilitate attachment of the surface to the body, e.g. the floor of the labial vestibule around the urethral meatus, of the patient.
A particularly preferred embodiment of the invention is a device as described above for alleviating urinary incontinence in a female patient, in which said first member is a substantially circular or oval shaped flange having a first surface at least a portion of which is coated with a biologically-compatible adhesive so that said first surface is attachable to the floor of the labial vestibule, and said valve is defined by a foldable extension of the flange, which extension forms two foldable flaps having a closed position wherein the flaps are folded inwardly to form a closure over the aperture and an open position wherein the flaps extend outwardly to define a flow path from the aperture to the exterior.
The valve of the invention may have any one of a number of different configurations.
In each preferred version of the valve, the aperture is preferably funnel-shaped and the wall of the funnel is defined by the first surface of the flange. However, the positioning of the portions of the flange which act upon the foldable flaps to effect closure of the valve, each of which is herein designated as a "pincher", relative to the other portions, differs in the various versions. The configuration of the portions which make up the valve and the foldable flaps thereof and the spatial relationship of these portions with respect to each other is described in detail hereinafter with reference to the embodiments illustrated in the accompanying drawings.
Each foldable flap of the valve is preferably made of a material which is sufficiently elastic to be folded and compressed or pinched a number of times without deterioration and the preferred material is a biologically compatible elastomer. Typically all components of the device are integral with each other and are made from the same elastomeric material.
A device suitable for a male patient is also included within the invention, and in this embodiment the first member will have the shape of a short condom instead of a flange.
Additionally the invention also encompasses an embodiment which may be used to control leakage from a body stoma and allow drainage therefrom when desired. The components of such an embodiment are analogous to those of the herein described embodiments for alleviating urinary incontinence.
The device of the invention will be particularly described with reference to preferred embodiments illustrated in the accompanying drawings, in which:
The device illustrated in
The device comprises a first member 1 having a body-contacting first surface 2 and an opposing second surface 3. In the embodiment illustrated the first member is a substantially circular flange, wherein at least a portion of the first surface 2 is coated with a medical adhesive. Alternatively the first member may have a substantially oval configuration or any other configuration which will facilitate placement over the urethral meatus with the minimum discomfort. The flange defines an aperture 4 which will be positioned over the urethral orifice when the first surface is attached to the patients body with the aid of the adhesive. The aperture has a funnel-shaped wall 5 which narrows to a neck 6 which acts as a pincher to close the valve as described hereinafter.
The device further comprises a second member 7 which is a valve mounted over the aperture. The valve is defined by a foldable extension of the flange which comprises two foldable flaps each comprising a dome portion 8 and a duct portion 9. As shown in FIG. 3 and
A second embodiment of the invention is illustrated in FIGS. 6,7 and 8. This embodiment also utilizes a valve defined by foldable flaps, but the configuration thereof differs somewhat from the configuration of
A further variation of the invention is a third embodiment as illustrated in
In each of the above-described embodiments the size of the flange is such that it may be realasably attached to the labial vestibule without discomfort to the patient The aperture should be large enough so that when it is positioned over the urethral orifice there should be sufficient clearance to facilitate micturition when desired. Typically the flange would have an external diameter of about 2 to 3 cm. depending upon the body size of the patient. The protruding dimension of the device should be no more than 1.5 to 2 cm. between the open and closed positions of the valve.
The incorporation of a valve as described above in a device according to any one of the preferred three embodiments described herein above provides a valuable means for the alleviation of urinary incontinence, particularly stress incontinence, in females, which prevents leakage and yet allows micturition when desired, with minimal discomfort and maximal ease of operation. By allowing micturition without the need to remove the device, the patient is provided with a device which is clearly advantageous over the various plugs and pads available heretofore.
The device according to the invention may be worn by the patient for as much as a whole day or even longer if the patient's condition so allows. The preferred device is intended to be disposable.
The device may be made with a type of valve other than valve as described herein: however, valves with a more complex mechanism would be more costly to produce and any valve which involves a complicated opening and closing procedure, particularly a procedure which takes more than a few seconds of time, should be avoided. Furthermore, it is important that operation of the valve should not significantly affect the attachment of the device to the body of the patent Additionally, the structure described herein may be made in one piece from the same elastomeric material, apart from the adhesive.
Thus, for the reasons of easy operation, ease of manufacture, low cost and disposability, at least, a device incorporating a valve, as herein described, is the preferred embodiment of the invention.
Polyak, Mark, Hauschild, Sidney F.
Patent | Priority | Assignee | Title |
6936052, | Mar 09 2001 | Boston Scientific Scimed, Inc | System for implanting an implant and method thereof |
6991597, | Mar 09 2001 | Boston Scientific Scimed, Inc | System for implanting an implant and method thereof |
7025772, | Mar 09 2001 | Boston Scientific Scimed, Inc | System for implanting an implant and method thereof |
7235043, | Mar 09 2001 | Boston Scientific Scimed, Inc | System for implanting an implant and method thereof |
7361138, | Jul 31 2003 | Boston Scientific Scimed, Inc | Bioabsorbable casing for surgical sling assembly |
7402133, | Dec 17 2002 | Boston Scientific Scimed, Inc | Spacer for sling delivery system |
7824326, | Jul 31 2003 | Boston Scientific Scimed, Inc. | Bioabsorbable casing for surgical sling assembly |
8033983, | Mar 09 2001 | Boston Scientific Scimed, Inc | Medical implant |
8162816, | Mar 09 2001 | Boston Scientific Scimed, Inc | System for implanting an implant and method thereof |
8617048, | Mar 09 2001 | Boston Scientific Scimed, Inc | System for implanting an implant and method thereof |
8632453, | Dec 17 2002 | Boston Scientific Scimed, Inc. | Spacer for sling delivery system |
Patent | Priority | Assignee | Title |
2510766, | |||
3547401, | |||
3758073, | |||
3841304, | |||
4210132, | Jul 26 1978 | The Kendall Company | Artificial sphincter |
4344434, | Jun 01 1981 | Santa Barbara Medical Foundation Clinic | Ileostomy appliance and method for implanting the same |
4552128, | Dec 29 1983 | HABLEY MEDICAL TECHNOLOGY CORPORATION, A CORP OF CA | Elastomechanical sphincter |
4587954, | Dec 29 1983 | HABLEY MEDICAL TECHNOLOGY CORPORATION, A CORP OF CA | Elastomeric prosthetic sphincter |
4631062, | May 21 1984 | Kimberly-Clark Worldwide, Inc | Labial sanitary pad |
4690677, | Sep 25 1985 | DALTEX MEDICAL SCIENCES, INC , 20 EXCHANGE PLACE, NEW YORK, NEW YORK, 10005 | Urine collection system for females |
4822333, | Sep 02 1987 | Urethral endoprosthesis | |
4850953, | Jul 27 1987 | HABLEY MEDICAL TECHNOLOGY CORPORATION, 22982 ALCALDE, A CA CORP | Gastrostomy valve |
4968294, | Feb 09 1989 | OPTICON MEDICAL INC | Urinary control valve and method of using same |
5074855, | Jan 10 1991 | Procter & Gamble Company, The | Urinary incontinence pad |
5082006, | Sep 15 1987 | JONASSON, LINDA | Device for preventing involuntary micturition |
5114398, | Feb 27 1990 | Urocath Corporation | Female incontinence control device with mechanically operable valve |
5140999, | Sep 30 1991 | Primed International Corp.; PRIMED INTERANTIONAL CORP A CORPORATION OF MN | Urinary incontinence valve device |
5336208, | Jan 10 1991 | Procter & Gamble Company, The | Urinary incontinence pad |
5352182, | May 27 1992 | Product and method to treat female incontinence | |
5483976, | Dec 31 1990 | UroMed Corporation | Mechanically actuated urethral plug assembly and method for controlling urinary incontinence |
5640976, | Jun 06 1995 | Iotek, Inc. | Incontinence plug anchor |
5662582, | Feb 27 1995 | Iotek, Inc, | Everting incontinence plug |
5711314, | Nov 08 1996 | CYSTOMEDIX, INC | Urinary incontinence valve with distal and proximal anchoring means |
5722931, | Mar 05 1996 | IMAGYN MEDICAL TECHNOLOGIES, INC | Female incontinence device |
5752525, | Aug 16 1991 | UroMed Corporation | Urethral plug assembly having adhesive for enhanced sealing capabilities and method of using said plug assembly |
5755236, | Dec 12 1996 | Female incontinence device | |
5813974, | Dec 19 1995 | Device for women suffering from incontinence | |
6030337, | Jul 30 1998 | Boston Scientific Corporation; Boston Scientific Scimed, Inc | Continence augmentor and methods for urinary control |
6056687, | Dec 04 1997 | Boston Scientific Corporation; Boston Scientific Scimed, Inc | Device for alleviating urinary incontinence |
6200261, | Mar 04 1998 | Boston Scientific Corporation; Boston Scientific Scimed, Inc | Valve and methods for urinary control |
EP535778, | |||
EP780105, | |||
WO9206731, | |||
WO9211826, | |||
WO9219192, | |||
WO9308765, | |||
WO9426915, | |||
WO9508968, | |||
WO9626688, | |||
WO9639096, | |||
WO9639989, | |||
WO9639990, | |||
WO9639991, | |||
WO9706758, | |||
WO9717909, | |||
WO9725947, | |||
WO9819640, | |||
WO9825555, | |||
WO59403, | |||
WO151578, | |||
WO9717909, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Apr 17 2000 | AMERICAN MEDICAL SYSTEMS, INC | BANK OF AMERICA, N A , AS AGENT | NOTICE OF GRANT OF SECURITY INTEREST | 014210 | /0936 | |
Apr 28 2000 | American Medical Systems Inc. | (assignment on the face of the patent) | / | |||
Jul 01 2004 | BANK OF AMERICA, N A | AMERICAN MEDICAL SYSTEMS, INC | RELEASE OF SECURITY INTEREST | 015621 | /0551 | |
Jul 17 2006 | BANK OF AMERICA, N A , AS AGENT | AMERICAN MEDICAL SYSTEMS, INC | RELEASE OF SECURITY INTEREST SUPERCEEDING RELEASE RECORDED ON JULY 30, 2004 AT REEL FRAME 015621 0551 | 017957 | /0644 | |
Jul 18 2006 | AMERICAN MEDICAL SYSTEMS, INC | AMS Research Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 017971 | /0777 | |
Jul 20 2006 | AMERICAN MEDICAL SYSTEMS, INC | CIT HEALTHCARE LLC | SECURITY AGREEMENT | 018132 | /0639 | |
Apr 12 2011 | CIT HEALTHCARE LLC | AMERICAN MEDICAL SYSTEMS, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 026142 | /0569 | |
Jun 17 2011 | AMS Research Corporation | MORGAN STANLEY SENIOR FUNDING, INC , AS ADMINISTRATIVE AGENT | SECURITY AGREEMENT | 026632 | /0535 | |
Feb 28 2014 | MORGAN STANLEY SENIOR FUNDING, INC , AS ADMINISTRATIVE AGENT | AMS Research Corporation | RELEASE OF PATENT SECURITY INTEREST | 032380 | /0053 | |
Feb 28 2014 | ENDO PHARMACEUTICALS SOLUTIONS, INC | DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT | GRANT OF SECURITY INTEREST IN PATENTS | 032491 | /0440 | |
Feb 28 2014 | ENDO PHARMACEUTICALS, INC | DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT | GRANT OF SECURITY INTEREST IN PATENTS | 032491 | /0440 | |
Feb 28 2014 | Laserscope | DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT | GRANT OF SECURITY INTEREST IN PATENTS | 032491 | /0440 | |
Feb 28 2014 | AMERICAN MEDICAL SYSTEMS, INC | DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT | GRANT OF SECURITY INTEREST IN PATENTS | 032491 | /0440 | |
Feb 28 2014 | AMS Research Corporation | DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT | GRANT OF SECURITY INTEREST IN PATENTS | 032491 | /0440 | |
Dec 17 2014 | AMS RESEARCH CORPATION | AMS Research, LLC | CHANGE OF NAME SEE DOCUMENT FOR DETAILS | 037300 | /0318 | |
Dec 17 2014 | AMS Research Corporation | AMS Research, LLC | CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0318 ASSIGNOR S HEREBY CONFIRMS THE CHANGE OF NAME | 039919 | /0017 | |
Feb 27 2015 | AMS Research, LLC | APHRODITE WOMEN S HEALTH, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 037473 | /0260 | |
Aug 03 2015 | DEUTSCHE BANK AG NEW YORK BRANCH | Laserscope | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 036285 | /0146 | |
Aug 03 2015 | DEUTSCHE BANK AG NEW YORK BRANCH | AMS Research, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 036285 | /0146 | |
Aug 03 2015 | DEUTSCHE BANK AG NEW YORK BRANCH | AMERICAN MEDICAL SYSTEMS, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 036285 | /0146 | |
Sep 29 2015 | APHRODITE WOMEN S HEALTH, LLC | ASTORA WOMEN S HEALTH, LLC | CHANGE OF NAME SEE DOCUMENT FOR DETAILS | 037473 | /0354 | |
Dec 22 2016 | ENDO HEALTH SOLUTIONS INC | Boston Scientific Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 043778 | /0302 | |
Dec 22 2016 | Boston Scientific Corporation | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 043780 | /0316 | |
Dec 22 2016 | ASTORA WOMEN S HEALTH HOLDINGS, LLC | Boston Scientific Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 043778 | /0302 | |
Dec 22 2016 | ASTORA WOMEN S HEALTH, LLC | Boston Scientific Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 043778 | /0302 | |
Apr 27 2017 | ASTORA WOMEN S HEALTH, LLC | Wilmington Trust, National Association, as Collateral Trustee | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 042743 | /0278 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | ENDO PHARMACEUTICALS SOLUTIONS INC FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | GENERICS BIDCO I, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | GENERICS INTERNATIONAL US , INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | PAR PHARMACEUTICAL, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | PAR STERILE PRODUCTS, LLC FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | QUARTZ SPECIALTY PHARMACEUTICALS, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | SLATE PHARMACEUTICALS, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | Endo Pharmaceuticals Inc | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | ENDO GENERIC HOLDINGS, INC FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | DAVA PHARMACEUTICALS, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | DAVA INTERNATIONAL, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | BIOSPECIFICS TECHNOLOGIES CORP | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | Auxilium US Holdings, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | AUXILIUM PHARMACEUTICALS, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | ASTORA WOMEN’S HEALTH LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | ASTORA WOMEN’S HEALTH HOLDINGS, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | ACTIENT PHARMACEUTICALS LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 | |
Apr 23 2024 | WILMINGTON TRUST, NATIONAL ASSOCIATION | VINTAGE PHARMACEUTICALS, LLC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 067240 | /0001 |
Date | Maintenance Fee Events |
Apr 10 2006 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Mar 31 2010 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Mar 26 2014 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Oct 08 2005 | 4 years fee payment window open |
Apr 08 2006 | 6 months grace period start (w surcharge) |
Oct 08 2006 | patent expiry (for year 4) |
Oct 08 2008 | 2 years to revive unintentionally abandoned end. (for year 4) |
Oct 08 2009 | 8 years fee payment window open |
Apr 08 2010 | 6 months grace period start (w surcharge) |
Oct 08 2010 | patent expiry (for year 8) |
Oct 08 2012 | 2 years to revive unintentionally abandoned end. (for year 8) |
Oct 08 2013 | 12 years fee payment window open |
Apr 08 2014 | 6 months grace period start (w surcharge) |
Oct 08 2014 | patent expiry (for year 12) |
Oct 08 2016 | 2 years to revive unintentionally abandoned end. (for year 12) |